Abstract
Recently, much attention has focussed on the possible beneficial effects of a-adrenergic-blocking agents in acute myocardial ischaemia. Prazosin and phentolamine prevent ventricular fibrillation induced by coronary artery occlusion and reperfusion in cats [1], although they fail to do so in dogs [2]. Minor antiarrhythmic effects of phentolamine have been reported in patients with acute myocardial infarction [3]. More importantly, afterload reduction by phentolamine has been shown to improve haemodynamics in the setting of acute myocardial infarction complicated by left ventricular failure and/or hypertension [4–6]. However, since phentolamine may incresae heart rate [5, 6], its effect on severity of ischaemia remains uncertain [7]. We [2] have previously shown that phentolamine and prazosin fail to improve severity of ischaemia (estimated from intramyocardial C02 tension), coronary collateral blood flow and arrhythmias during acute coronary occlusion in dogs.
Sermion, Sermion Forte, Farmitalia
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Sheridan DJ, Penkoske PA, Sobel BE, Corr PB (1980) Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest 65: 161
Bolli R, Fisher DJ, Taylor AA, Young JB, Miller RR (1984) Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog. J Mol Cell Cardiol 16: 1101
Gould L, Reddy CVR, Weinstein T, Gomprecht RF (1975) Antiarrhythmic prophylaxis with phentolamine in acute myocardial infarction. J Clin Pharmacol 15: 191
Chatteijee K, Parmley WW, Ganz W, Forrester J, Walinsky P, Crexells C, Swan HJC (1973) Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction. Circulation 48: 1183
Perret C, Gardaz JP, Reynaert M, Grimbert F, Enrico JF (1975) Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction: Hemodynamic study. Br Heart J 37: 640
Kelly DT, Delgado CE, Taylor DR, Pitt B, Ross RS (1973) Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation 47: 729
Bolli R (1982) Protection of ischemic myocardium in experimental animals and in man: a review. Cardiovasc Res Ctr Bull 21: 1 - 33
Arcari G, Dorigotti L, Fregman CB, Glasser AH (1968) Vasodilating and alpha receptor blocking activity of a new ergoline derivative. Br J Pharmacol 34: 700
Arcari G, Bernardi L, Bosigio G, Coda S, Fregnan GB, Glasser AH (1972) 10-methoxyergoline derivatives as a-adrenergic blocking agents. Experientia 28: 819
Huguet F, Biziere K, Breteau M, Narcisse G (1980) Effets de la nicergoline sur divers neu-rorecepteurs centraux: Profil neurochimique. J Pharmacol 11: 257
Pornin M, Roland E, Lardoux H, Sellier P, Ourbak P, Maurice P (1980) Effets hemodyna- miques de la prazosine orale et de la nicergoline intraveneuse dans l’insuffisance cardiaque chronique. Ann Cardiol Angeiol (Paris) 29: 379
Boismare F, Lefrancois J (1980) Hemodynamic effects of nicergoline in man at rest and during exercise. Clin Exp Pharmacol Physiol 7: 105
Merillon JP, Morgant C, Lerallut JF, Chastre J, Motte G, Gourgon R (1981) Modifications des propriétés physiques du système arteriel et de l’impedance aortique après nicergoline dans l’insuffisance cardiaque et l’hypertension arterielle permanente. In: Boismare F, Cambier J, Gourgon R, Letac B, Safar M, Schmitt M (eds) Les alpha-bloquants. Pharmacologie experimentale et clinique (International Symposium). Masson, Paris, p 100
Schmitt H, Laubie M, Fenard S (1971) Effets hemodynamiques des alcaloides de l’ergot de seigle. J Pharmacol 2: 131
Bolli R, Ware JA, Brandon TA, Weilbaecher DG, Mace ML (1984) Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist. J Am Coll Cardiol 3: 1417
Migne J, Saint-Maurice JP, Santonja R, Kunz S (1974) Activité anti-agregante plaquettaire. Effets d’un alpha-bloquer: La nicergoline. Sem Hop Paris 10: 649
LeMenn R, Migne J, Prost-Dvojakovie RJ (1977) Etude ultrastructurale de l’action d’un an- ti-agregant sur les plaquettes sanguines. Application a la nicergoline. Therapie 32: 205
Lagarde M, Guichardant M, Chazi I, Dechavanne M (1980) Nicergoline, an anti-aggregat- ing agent which inhibits release of arachidonic acid from human platelet phospholipids. Prostaglandins 19: 551
Rafelson ME, Migne J, Santonja R, Derouette JC, Robert L (1980) Effect of an alpha-blocking agent, nicergoline, on the interaction between blood platelets, elastin and endothelial cells. Biochem Pharmacol 19: 943
Pogliani E, Della Volpe A, Ferrari R, Recalcati P, Praga C (1975) Inhibition of human platelet aggregation by oral administration of nicergoline. A double-blind study. Farmaco 30: 630
Bolli R, Brandon TA, Luck JC, Miller RR, Entman ML (1983) Deleterious effects of incomplete myocardial reperfusion on ventricular arrhythmias. J Am Coll Cardiol 1: 1111–1118
Bolli R, Goldstein RE, Davenport N, Epstein SE (1981) Influence of sulfinpyrazone and naproxen on infarct size in the dog. Am J Cardiol 47: 841–847
Bolli R, Kuo LC, Roberts R (1984) Influence of acute arterial hypertension on myocardial infarct size in dogs without left ventricular hypertrophy. J Am Coll Cardiol 4: 522
Khuri SF, O’Riordan J, Flaherty JT, Brawley RK, Donahoo JS, Gott VL (1975) Mass spectrometry for the measurement of intramyocardial gas tensions: Methodology and application to the study of myocardial ischemia. In: Roy PE, Rona G (eds) Recent advances in studies on cardiac structure and metabolism, vol 10. University Park Press, Baltimore, p 539
Khuri SF, Flaherty JT, O’Riordan JB, Pitt B, Brawley RK, Donahoo JS, Gott VL (1975) Changes in intramyocardial ST segment voltage and gas tensions with regional myocardial ischemia in the dog. Circ Res 37: 455
Bolli R, Brandon TA, Risher DJ, Miller RR (1982) Ischemic determinants of ventricular arrhythmias during coronary artery occlusion and reperfusion (abstract). Clin Res 30: 174A
Lievre M, Ollagnier M, Faucon G (1979) Influence of nicergoline on cerebral blood flow and sympatholytical properties. Arzneimittelforsch 29: 1227
Nickerson H, Hollenberg NN (1967) Blockade of oc-adrenergie receptors. In: Root WS, Hoffmann FG (eds) Physiological pharmacology. Academic, London, p 243
Venu RDL (1978) Clinical pharmacology of ergot alkaloids in senile cerebral insufficiency. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, p 558 (Handbook of experimental pharmacology, vol 49 )
Levenson JA, Roland E, Toto Mou Kouo J, Simon A, Safar M (1980) Action intraveineuse de la nicergoline dans l’hypertension arterielle. Rev Med Interne 1: 123
Clark BJ, Chu D, Aelling WH (1978) Actions on the heart and circulation. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, p 356 (Handbook of experimental pharmacology, vol 49 )
Bolli R, Brandon TA, DeBauche TL, Miller RR (1982) Alpha-adrenergic blockade does not prevent spontaneous platelet-mediated thrombosis in stenosed coronary arteries ( Abstract ). Am J Cardiol 49: 976
Neill WA, Phelps NC, Oxendine JM, Mahler DJ, Sim DN (1973) Effect of heart rate on coronary blood flow distribution in dogs. Am J Cardiol 32: 306
Becker L (1976) Effect of tachycardia on left ventricular blood flow distribution during coronary occlusion. Am J Physiol 230: 1072
Brown BG, Gundel WD, Gott VL, Covell JW (1974) Coronary collateral flow following acute coronary occlusion: a diastolic phenomenon. Cardiovasc Res 8: 621
Grayson J, Irvine M, Parratt JR, Cunningham J (1968) Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res 2: 54
Forrester JS, Diamond G, Chatteijee K, Swan HJC (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 295: 1356
Bolli R, Brandon TA, Weilbaecher DG, Mace ML (1985) Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries. Cardiovas Res 19: 146
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bolli, R. (1986). Salutary Actions of Nicergoline During Experimental Coronary Artery Occlusion and Reperfusion. In: Heidrich, H. (eds) Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70786-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-70786-5_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-15901-8
Online ISBN: 978-3-642-70786-5
eBook Packages: Springer Book Archive